Indian drugmaker Sun Pharma to buy Daiichi Sankyo's stake in Ranbaxy Laboratories

Ananth Baliga MUMBAI, April 7 (UPI) -- Sun Pharma will acquire fellow Indian generic drugmaker Ranbaxy Laboratories, including Daichii Sankyo's majority stake in the latter for $3.2 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.